Automated iPSC Isolation via Surface Marker Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing induced pluripotent stem cells (iPSCs) are time-consuming and labor-intensive, requiring multiple passaging and sub-cloning to achieve vector-free cell lines, and pose risks due to viral vector integration, which complicates clinical applications.
Innovation Solution
The development of systems and methods that automate the isolation and purification of iPSCs by selectively binding to cell surface markers using candidate binding agents such as antibodies, biotinylated beads, and magnetic nanoparticles, enabling simultaneous separation of heterogeneous mixtures across different vector families and subtypes, and allowing for the creation of vector-free or mixed vector sub-colonies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If manual single colony sub-cloning is performed repeatedly to achieve vector-free iPSC lines, then vector-free cell lines can be obtained, but the process becomes extremely time-consuming and labor-intensive
Solution Approach 1:
The patent replaces manual mechanical operations (hand-picked colony selection and transfer) with automated image analysis and robotic liquid handling systems. The system captures images of cell colonies, automatically identifies and selects colonies expressing desired markers, and performs precise liquid handling for sub-cloning, thereby eliminating the time-consuming manual processes while maintaining the ability to obtain vector-free lines
Solution Approach 2:
The patent uses image capture and digital copying of colony visual information to create a virtual representation of the cell culture state. This allows automated analysis and selection without physical manipulation at each step, enabling parallel processing and significantly reducing the time required compared to sequential manual inspection and selection
2Productivity
If viral vectors are used to produce iPSCs, then cellular reprogramming can be achieved, but viral vector integration into host genomes creates tumorigenicity risks
Solution Approach 1:
The patent performs preliminary selection of colonies that have lost viral vector integration by detecting the absence of vector-derived markers or presence of vector-free phenotypes. By identifying and selecting these colonies before further use, the system ensures that subsequent cell lines are vector-free, eliminating tumorigenicity risks while maintaining reprogramming efficiency
Solution Approach 2:
The patent extracts and removes colonies containing integrated viral vectors from the population through automated identification and selective sub-cloning. By taking out the harmful element (vector-containing colonies) and isolating only vector-free colonies, the system achieves both high productivity in generating iPSCs and elimination of tumorigenicity risks
3Measurement precision
If repeated analytical techniques such as immunostaining or PCR protocols are performed for colony verification, then vector-free status can be confirmed, but the complexity and time required increase significantly
Solution Approach 1:
The patent merges multiple analytical techniques into a single integrated automated workflow. The system combines image capture, automated image analysis for marker detection, and robotic liquid handling for verification assays, performing multiple verification steps simultaneously or in streamlined sequence, thereby maintaining measurement precision while reducing overall process complexity and time
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces the time and effort required to obtain vector-free iPSC colonies, enhances safety by minimizing viral vector integration, and facilitates their use in research, diagnostics, and cell therapies.
Implementation Method 1
separating the iPSCs from the colony of cells into vector-based lineages determined by mapped cell surface markers via single bead separation, column chromatography, serial separation, microfluidic channel separation, magnetic bead binding, antibody binding
Implementation Method 2
selectively binding to one or more corresponding protein markers expressed on the surface of a cell that indicate that cellular reprogramming has occurred
Data Source
AI summary
Described herein are various systems, methods, and apparatus for systematic creation of isolated homogeneous colonies of cells from vector-based lineages. The vector-based lineages may originate from multiple types of viral vector families (e.g., Paramyx-oviridae, Retroviridae, Parvoviridae) or non-natural engineered vectors or a plurality of vector combinations, for example. In certain embodiments, the isolated homogeneous colonies of cells are vector-free sub-colonies; in other embodiments, the isolated homogeneous colonies of cells are homogeneous vector sub-colonies. In other embodiments, vector mixed sub-colonies are created. The disclosed systems, methods, and apparatus are useful for inducible pluripotent stem cell (iPSC) production and work by selectively binding to one or more corresponding protein markers expressed on the surface of a cell that indicate that cellular reprogramming has occurred. Software is used to automate the purification and isolation of the iPSCs produced.